Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy

Malignant glioma, or glioblastoma, is the most common and lethal form of brain tumor with a median survival time of 15 months. The established therapeutic regimen includes a tripartite therapy of surgical resection followed by radiation and temozolomide (TMZ) chemotherapy, concurrently with radiatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Sadhak Sengupta, Jaclyn Marrinan, Caroline Frishman, Prakash Sampath
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/831090
Tags: Add Tag
No Tags, Be the first to tag this record!